glp 1 investing GLP-1 Agonists Market Report 2025-2033, By Product, Molecule, and Geo Many patients may keep off

Description

The index SNP (rs9394561) and the missense SNP identified in this study (rs10305420) are highlighted

But healthcare professionals (such as the telehealth physicians employed by Willow) are free to prescribe those drugs off-label, and, as we have seen with Hims/Hers et al., there are few regulations on how these digital/telehealth/pharmacy operations can promote themselves

Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society. American Journal of Lifestyle Medicine , 30 May 2025, Locatelli, Joo Carlos, et al

Interestingly, monomeric GLP-1R agonists, like semaglutide and liraglutide, as well as dual GLP-1R agonists like tirzepatide, have been FDA-approved for the treatment of T2DM and metabolic disorders, including chronic weight management in adults with obesity [32,33]